Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor system

Behavioural Pharmacology

Volumn 26, Issue , 2015, Pages 654-663

  Donahue, Rachel J ^a   Landino, Samantha M ^a   Golden, Sam A ^b   Carroll, F Ivy ^c   Russo, Scott J ^b   Carlezon, William A ^a  

^a MCLEAN HOSPITAL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c RTI INTERNATIONAL   (United States)

Author keywords

intracranial self stimulation; kappa opioid receptor; mouse; social defeat stress

Indexed keywords

DYNORPHIN; KAPPA OPIATE RECEPTOR; MESSENGER RNA; DOPAMINE TRANSPORTER;

ACUTE SOCIAL DEFEAT STRESS; ACUTE STRESS; ANHEDONIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN NERVE CELL; CHRONIC SOCIAL DEFEAT STRESS; CHRONIC STRESS; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; SELF STIMULATION; SOCIAL AVOIDANCE BEHAVIOR; SOCIAL STRESS; ACUTE DISEASE; ANIMAL; C57BL MOUSE; CHRONIC DISEASE; COMPARATIVE STUDY; COPING BEHAVIOR; GENETICS; KNOCKOUT MOUSE; MENTAL STRESS; METABOLISM; NERVE CELL; PHYSIOLOGY; PSYCHOLOGIC TEST; SOCIAL BEHAVIOR; SOCIAL DOMINANCE; TIME FACTOR;

ACUTE DISEASE; ANHEDONIA; ANIMALS; CHRONIC DISEASE; DOMINANCE-SUBORDINATION; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DYNORPHINS; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; NUCLEUS ACCUMBENS; PSYCHOLOGICAL TESTS; RECEPTORS, OPIOID, KAPPA; RESILIENCE, PSYCHOLOGICAL; RNA, MESSENGER; SELF STIMULATION; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 84942083756     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0000000000000155     Document Type: Article

References (53)

1. Al-Hasani R, McCall JG, Bruchas MR (2013). Exposure to chronic mild stress prevents kappa opioid-mediated reinstatement of cocaine and nicotine place preference. Front Pharmacol 4:1-10.
2. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS (1993). Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264:489-495.
3. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, et al. (2006). Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311:864-868.
4. Bérubé P, Laforest S, Bhatnagar S, Drolet G (2013). Enkephalin and dynorphin mRNA expression are associated with resilience or vulnerability to chronic social defeat stress. Physiol Behav 122:237-245.
5. Bruchas MR, Xu M, Chavkin C (2008). Repeated swim-stress induces kappa-opioid mediated activation of ERK1/2 MAPK. Neuroreport 19:1417-1422.
6. Bruchas MR, Land BB, Chavkin C (2010). The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res 1314:44-55.
7. Bruchas MR, Schindler AG, Shankar H, Messinger DI, Miyatake M, Land BB, et al. (2011). Selective p38alpha MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron 71:498-511.
8. CarlezonWA Jr, Chartoff EH (2007). Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2:2987-2995.
9. Carlezon WA Jr, Beguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, et al. (2006). Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316:440-447.
10. Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, et al. (2004). Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Eur J Pharmacol 501:111-119.
11. Chartoff EH, Papadopoulou M, MacDonald ML, Parsegian A, Potter D, Konradi C, Carlezon WA Jr (2009). Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue. Mol Pharmacol 75:704-712.
12. Chartoff E, Sawyer A, Rachlin A, Potter D, Pliakas A, Carlezon WA (2012). Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats. Neuropharmacology 62:167-176.
13. Chefer VI, Bäckman CM, Gigante ED, Shippenberg TS (2013). Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion. Neuropsychopharmacology 38:2623-2631.
14. Do Carmo GP, Folk JE, Rice KC, Chartoff E, Carlezon WA Jr (2009). The selective non-peptide delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats. Eur J Pharmacol 604:58-65.
15. Donahue RJ, Muschamp JW, Russo SJ, Nestler EJ, Carlezon WA Jr (2014). Effects of striatal ΔFos B overexpression and ketamine on social defeat stress-induced anhedonia in mice. Biol Psychiatry 76:550-558.
16. Donzanti BA, Althaus JS, Payson MM, Von Voigtlander PF (1992)Kappa agonist-induced reduction in dopamine release: side of action and tolerance. Res Commun Chem Pathol Pharmacol 78:pp. 192-210.
17. Golden SA, Covington HE III, Berton O, Russo SJ (2011). A standardized protocol for repeated social defeat stress in mice. Nat Protoc 6:1183-1191.
18. Golden SA, Christoffel DJ, Heshmati M, Hodes GE, Magida J, Davis K, et al. (2013). Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nat Med 19:337-344.
19. John CS, Smith KL, Van't Veer A, Gompf HS, Carlezon WA Jr, Cohen BM, et al. (2012). Blockade of astrocytic glutamate uptake in the prefrontal cortex induces anhedonia. Neuropsychopharmacology 37:2467-2475.
20. Keeny A, Jessop DS, Harbuz MS, Marsden CA, Hogg S, Blackburn-Munro RE (2006). Differential effects of acute and chronic social defeat stress on hypothalamic-pituitary-adrenal axis function and hippocampal serotonin release in mice. J Neuroendocrinol 18:330-338.
21. Kessler RC (1997). The effects of stressful life events on depression. Annu Rev Psychol 48:191-214.
22. Knoll AT, Carlezon WA Jr (2010). Dynorphin, stress, and depression. Brain Res 1314:56-73.
23. Knoll AT, Meloni EG, Thomas JB, Caroll FI, Carlezon WA Jr (2007). Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther 323:838-845.
24. Knoll AT, Muschamp JW, Sillivan SE, Fergeson D, Dietz DM, Meloni EG, et al. (2011). Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biol Psychiatry 70:425-433.
25. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, et al. (2007). Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131:391-404.
26. Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008). The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28:407-414.
27. Land BB, Bruchas MR, Schattauer S, Giardino WJ, Aita M, Messigner D, et al. (2009). Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. PNAS 106:19168-19173.
28. Lemos JC, Wanat MJ, Smith JS, Reyes BAS, Hollon NG, Van Bockstaele EJ, et al. (2012). Severe Stress switches CRF action in the nucleus accumbens from appetitive to aversive. Nature 490:402-406.
29. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, et al. (2003). Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305:323-330.
30. Maisonneuve IM, Archer S, Glick SD (1994). U50,488, a κ-opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci Lett 181:57-60.
31. McLaughlin JP, Marton-Popovici M, Chavkin C (2003). Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23:5674-5683.
32. McLaughlin JP, Li S, Valdez J, Chavkin TA, Chavkin C (2006). Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system. Neuropsychopharmacology 31:1241-1248.
33. Melief EJ, Miyatake M, Carroll FI, Beguin C, Carlezon WA Jr, Cohen BM, et al. (2011). Duration of action of a broad range of selective kappa-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation. Mol Pharmacol 80:920-929.
34. Muschamp JW, Van't Veer A, Parsegian A, Gallo MS, Chen M, Neve RL, et al. (2011). Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats. J Neurosci 31:3095-3103.
35. Muschamp JW, Nemeth CL, Robison AJ, Nestler EJ, Carlezon WA Jr (2012). ΔFosB enhances the rewarding effects of cocaine while reducing the pro-depressive effects of the kappa-opioid receptor agonist U50488. Biol Psychiatry 71:44-50.
36. Nabeshima T, Katoh A, Wada M, Kameyama T (1992). Stress-induced changes in brain Met-enkephalin, Leu-enkephalin and dynorphin concentrations. Life Sci 51:211-217.
37. Nestler EJ, Carlezon WA Jr (2006). The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151-1159.
38. Newton SS, Thome J, Wallace TL, Shirayama Y, Schlesinger L, Sakai N, et al. (2002). Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci 22:10883-10890.
39. Parlato R, Rieker C, Turiault M, Tronche F, Schutz G (2006). Survival of DA neurons is independent of CREM upregulation in absence of CREB. Genesis 44:454-464.
40. Pfeiffer A, Brantl V, Herz A, Emrich HM (1986). Psychotomimesis mediated by kappa opiate receptors. Science 233:774-776.
41. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA Jr (2001). Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci 21:7397-7403.
42. Ribeiro SC, Kennedy SE, Smith YR, Stohler CS, Zubieta JK (2005). Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Prog Neuropsychopharmacol Biol Psychiatry 29:1264-1280.
43. Shirayama Y, Ishida H, Iwata M, Hazama GI, Kawahara R, Duman RS (2004). Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem 90:1258-1268.
44. Svingos AL, Colago EE, Pickel VM (1999). Cellular sites for dynorphin activation of κ-opioid receptors in the rat nucleus accumbens shell. J Neurosci 19:1804-1813.
45. Takahashi M, Senda T, Tokuyama S, Kaneto H (1990). Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia. Japan J Pharmacol 53:487-494.
46. Todtenkopf MS, Marcus JF, Portoghese PS, Carlezon WA Jr (2004). Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berl) 172:463-470.
47. Tramullas M, Dinan TG, Cryan JF (2012). Chronic psychosocial stress induces visceral hyperalgesia in mice. Stress 15:281-292.
48. Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, et al. (2007). Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320:1-13.
49. Van't Veer A, Carlezon WA Jr (2013). Role of kappa-opioid receptors in stress and anxiety-related behavior. Psychopharmacology (Berl) 229:434-452.
50. Van't Veer A, Bechtholt AJ, Onvani S, Potter D, Wang Y, Liu-Chen LY, et al. (2013a). Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity. Neuropsychopharmacology 38:1585-1597.
51. Van't Veer AV, Carroll FI,Cohen BM, Carlezon WA Jr (2013b). Disruption of kappa opioid receptor function reduces stress effects on anxiety-like behavior. San Diego, CA: Society for Neuroscience.
52. Vialou V, Robison AJ, Laplant QC, Covington HE 3rd, Dietz DM, Ohnishi YN, et al. (2010). DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci 13:745-752.
53. Wise RA, Rompré PP (1989). Brain dopamine and reward. Annu Rev Psychol 40:191-225.